Exosome Skincare Explained: Plant vs Human Exosomes, UK Law, and What Korean Labels Really Mean

Quick answer

Exosomes are tiny bubbles that cells release to carry messages (proteins, fats and genetic material) to other cells. Skincare brands use them as "regenerative" ingredients.

The source is a critical legal and scientific distinction. Cells, tissues and products of human origin are prohibited in GB cosmetics under Annex II entry 416, a restriction relevant to human-derived exosome preparations. Plant, microbial and animal products still need ingredient-specific legal review and a full cosmetic safety assessment; they are not automatically approved because of their source. Most early clinical studies used human stem cell exosomes, often with microneedling or laser, so you can't apply those results to a plant-exosome serum.

In this guide

• What are exosomes?
• What the 2026 research update adds
• Types of exosome ingredients
• UK law: why human exosomes are banned
• Three separate legal and scientific questions
• How to read an exosome label
• What the evidence shows
• Exosomes vs PDRN
• Exosome treatments in UK clinics
• Who should avoid exosome products
• Frequently asked questions
• Exosome product due-diligence checklist for UK consumers
• References

What are exosomes?

Exosomes are a type of extracellular vesicle (EV): membrane-wrapped particles roughly 30–150 nanometres across. Cells release them naturally. When another cell takes them up, their contents can change how that cell behaves.

In aesthetics, the word "exosome" is used loosely. A 2026 review noted that many products and studies call their ingredient "exosomes" without proving the particles are true exosomes rather than other vesicles (Contreras & Ariza-Donado, 2026). On a cosmetic label, "exosome" is a marketing term as much as a scientific one.

What the 2026 research update adds

A particularly relevant scoping review published on 15 October 2026 screened 2,394 records and included 18 studies of topical exosome approaches for skin rejuvenation. Ten used delivery modalities alongside the vesicles, while eight studied topical application alone. It also reviewed 20 commercially promoted “exosome” products and found poor disclosure of how materials were isolated, processed or stored. That matters directly to a reader browsing a Korean plant-exosome serum today: a favourable clinic study is not validation of an inexpensive leave-on cosmetic.

The review's authors concluded that human clinical studies remain scarce and standardisation is needed. This is a more useful conclusion than a star rating or a blanket claim that the next generation of skincare has been proved to regenerate skin.

Types of exosome ingredients

UK law: why human exosomes are banned

In Great Britain, cosmetics are regulated under the retained version of the EU Cosmetics Regulation 1223/2009. Its Annex II, entry 416, prohibits "cells, tissues or products of human origin" in cosmetics. Cosmetic classification and ingredient identity matter; do not treat a website's ingredient synonym as a binding regulatory ruling. Some secondary ingredient databases link human stem cell exosome preparations to this prohibition (CosIng record via CosIng Checker).

UK government has said the same thing directly. In November 2025, after a 5 News investigation found clinics using human stem cell exosome products, the Department for Business and Trade said cosmetics containing human exosomes are banned in the UK (Aesthetics Journal).

Why this matters for Korean skincare: Korea doesn't have a blanket ban. Its rules allow human cell and tissue culture media in cosmetics when they meet specific safety standards (ChemLinked). A product sold in Seoul may therefore be unsuitable or unlawful to place on the GB cosmetics market without ingredient-specific assessment; Northern Ireland requirements can differ. This is a real risk with grey-import and direct-from-Korea sellers.

Injecting any exosome product is a separate issue. Exosomes are not licensed medicines for injection in the UK. Treat any clinic offering exosome injections with caution, whatever the source.

Three separate legal and scientific questions

1. What is the source? Under Annex II entry 416, UK cosmetic rules prohibit cells, tissues and products of human origin. That is the decisive issue for human-derived extracellular-vesicle preparations sold as cosmetics.

2. What exactly is the material? “Plant exosomes”, “ferment vesicles”, “salmon exosomes”, extracts and cell-culture products do not all refer to the same scientific preparation. A manufacturer must establish identity, contamination profile, stability and safety. Being non-human does not mean an ingredient has blanket approval.

3. How is it supplied and used? A leave-on cosmetic, a topical product placed on deliberately damaged skin and an injectable intervention are different risk and regulatory situations. The product's classification and any medicine/device authorisation must be assessed individually. The UK's OPSS cosmetic guidance applies to GB cosmetic products, not automatically to every clinic procedure.

How to read an exosome label

The ingredient list (INCI) tells you more than the front of the pack.

Red flags for a UK purchase. Don't buy if the INCI includes:

• Anything starting with "Human", such as "Human Umbilical Mesenchymal Stem Cell Exosomes", "Human Adipocyte Conditioned Media Extract" or "Human Cord Blood ..."
• "Stem cell culture", "conditioned media" or "secretome" with no plant, microbial or animal source named
• No ingredient list at all, or a Korean-only label with no Responsible Person name and address

Potentially less concerning from a human-origin standpoint; still verify:

• A named plant source, such as rose, centella or ginseng, followed by "exosomes", "extracellular vesicles" or "callus culture"
• Named microbial ferments
• A clearly identified animal-origin ingredient, with traceability and a competent review of its specific legal status

Cosmetics sold in Great Britain must name a Responsible Person with a UK or EU address (GOV.UK). If it's missing, the product may not be legally on the UK market. Our guide to buying Korean skincare in the UK explains how to check.

What the evidence shows

Our reading of the evidence:

1. Much early evidence involves human-derived vesicles and/or skin-opening procedures. These data cannot establish efficacy of an ordinary plant-vesicle serum on intact skin.
2. Plant exosome serums on intact skin have very little human clinical data. Lab studies show activity, but that doesn't prove a visible benefit.
3. Exosome particles are large. Penetration through intact skin is uncertain without a procedure or a delivery system such as spicules.
4. Product standards and disclosure vary considerably. Two "exosome" serums can contain completely different things at completely different amounts.

Exosomes vs PDRN

If you're choosing one "regenerative" ingredient, PDRN has a more established medical literature, but that does not prove superiority for ordinary leave-on cosmetics. Read our PDRN guide. Many Korean products combine both. For other next-generation actives, see our advanced ingredients guide and EGF serum guide.

Exosome treatments in UK clinics

Some UK clinics offer "exosome facials", usually microneedling or laser followed by an exosome serum. Before booking, ask:

1. What is the exosome's source and the exact product? Ask to see the product and its ingredient list. Human-origin cosmetic products may fall under the Annex II prohibition; demand a formal legal and product assessment rather than assurances alone.
2. Is it applied to open skin or injected? Do not assume an exosome preparation is a UK-authorised injectable medicine; ask for verifiable MHRA authorisation for the named product and indication. Scoping-review data link injection to granulomas and necrosis.
3. Who is performing it, and what are their qualifications? Check that the clinic is properly registered with its local authority, and with the CQC where regulated activities are involved.
4. What happens if something goes wrong? Ask about aftercare and complications management.

Use our UK clinic directory to research providers.

Who should avoid exosome products

• Anyone with a history of skin cancer, or currently being treated for cancer, without specialist advice, given the growth-signalling content
• Pregnant or breastfeeding people, as there are no safety data
• People with active skin infection, eczema flares or broken skin
• Anyone offered exosome injections

Frequently asked questions

Are exosomes legal in UK skincare?

GB rules prohibit products of human origin in cosmetics under Annex II entry 416. Non-human-source vesicles are not automatically approved: the exact ingredient and finished product require legal and safety checks.

Are plant exosomes as good as human exosomes?

No comparative clinical evidence establishes equivalence. They're different materials with different contents.

What are salmon exosomes?

They're vesicles marketed from salmon-derived material, often alongside PDRN. Evidence is very limited.

Do exosome serums penetrate skin?

It's uncertain on intact skin. Most clinical studies applied them after microneedling or laser.

Are exosomes the same as stem cells?

No. They're vesicles released by cells, not cells. Human stem cell-derived exosomes are still prohibited in UK cosmetics because they are products of human origin.

Why are Korean exosome products different?

Rules and ingredient classifications differ across markets. Products lawful elsewhere are not automatically compliant for sale in GB. Always check the INCI of imported products.

Can I report a product I think contains human exosomes?

Yes. Contact your local Trading Standards service through Citizens Advice.

Exosome product due-diligence checklist for UK consumers

1. Request the full INCI and original source of the purported extracellular vesicles. “Human stem cell exosome” should trigger an immediate compliance concern for a cosmetic.
2. Ask for the supplier's characterisation (particle identity, source, purity, processing, testing) and whether the claims concern the actual finished product.
3. Verify GB Responsible Person information and current packaging—not just an overseas webshop image.
4. Separate ordinary cosmetics from microneedling, injection or treatment of open skin. Do not assume a product is sterile or a licensed medicine simply because it is used in a clinic.
5. Treat price, celebrity endorsements and “regeneration” vocabulary as marketing—not clinical evidence.

Bottom line: the most important distinction is source, product identity and application route. For most shoppers, a fragrance-free moisturiser with validated basic ingredients is more predictable than an exosome-labelled cosmetic whose source and clinical performance are undisclosed.

References

Research references below were retrieved via PubMed.

1. Wang OJE, Bajwa BB, Rivers JK. Exosome-based therapies in dermatology: a scoping review. J Drugs Dermatol. 2026;25(4):368–376. doi:10.36849/jdd.9610
2. Flores Rodríguez JC, et al. Efficacy of exosome-based therapies for skin rejuvenation: a systematic review of human studies. Cureus. 2026;18(2):e104182. doi:10.7759/cureus.104182
3. Alzahrani A, et al. Exosomes in skin rejuvenation: systematic review. Dermatol Pract Concept. 2026;16(1). doi:10.5826/dpc.1601a6462
4. Nahm WJ, et al. Exosomes in dermatology: a comprehensive review. Int J Dermatol. 2025;64(11):1995–2010. doi:10.1111/ijd.17903
5. Contreras C, Ariza-Donado A. Extracellular vesicles in regenerative and cosmetic medicine. Int J Mol Sci. 2026;27(12):5541. doi:10.3390/ijms27125541
6. Aesthetics Journal. Investigation reports human derived exosomes in UK clinics. 17 November 2025.
7. ChemLinked. Global regulations on exosomes in cosmetic products.
8. CosIng Checker. Human Umbilical Mesenchymal Stem Cell Exosomes, Annex II/416.
9. Knauer G, Chang A, Gupta A, et al. Clinical evidence and commercial landscape of topical exosomes for skin rejuvenation: a scoping review. Aesthet Surg J. 2026;46(11):NP148–NP157. doi:10.1093/asj/sjag141
10. Regulation (EC) No 1223/2009 on cosmetic products (as retained in GB), Annex II. legislation.gov.uk.
11. Office for Product Safety and Standards. Making cosmetic products available to consumers in Great Britain. GOV.UK.

How we researched this guide

This guide is based on peer-reviewed studies (retrieved via PubMed), UK regulatory and NHS guidance, and manufacturer or retailer information, which we identify as such wherever it is cited. Products named here have not been tested hands-on by us. The guide was medically reviewed by Khalid Anwar, GPhC-registered pharmacist, on 30 October 2026. It is general information, not individual medical advice. Spotted an error? Tell us via our corrections page.